Effects of positive and negative modulators of the γ-aminobutyric acid A receptor complex on responding under a differential-reinforcement-of-low-rate schedule of reinforcement in rats.
Relatively little is known about the behavioral effects of the neurosteroids compared with other drugs that modulate the γ-aminobutyric acid A (GABAA) receptor complex. This study examined the acute effects of pregnanolone and dehydroepiandrosterone (DHEA) in male rats responding under a differential-reinforcement-of-low-rate schedule of reinforcement. For comparison, three positive modulators of the GABAA receptor (lorazepam, ethanol, and pentobarbital), one negative modulator (β-CCM), and one neutral modulator (flumazenil) were tested. Pregnanolone was also administered in combination with DHEA to test for antagonism between these substances. Pregnanolone, lorazepam, and pentobarbital produced increases in responding at intermediate doses, and ethanol and pentobarbital produced decreases in responding at the highest doses tested. However, all four drugs dose-dependently decreased reinforced responding by decreasing inter-response times. DHEA, β-CCM, and flumazenil did not increase responding at intermediate doses or decrease reinforced responding. DHEA did not competitively antagonize the disruptive effects of pregnanolone. In summary, pregnanolone and DHEA produced effects on differential-reinforcement-of-low-rate responding that are similar to other positive and negative GABAA modulators, respectively, and do not produce these effects through a single binding site.
Amato
Russell J
RJ
aDepartment of Pharmacology and Experimental Therapeutics bNeuroscience Center cThe Comprehensive Alcohol Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Lewis
Peter B
PB
He
Hongbo
H
Winsauer
Peter J
PJ
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000704:Analysis of Variance; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D002243:Carbolines / Q000494:pharmacology; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology*; D003687:Dehydroepiandrosterone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D018682:GABA Agents / Q000494:pharmacology; D008297:Male; D011280:Pregnanolone / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000378:metabolism*; D012055:Reinforcement Schedule; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D000777:Anesthetics; D002243:Carbolines; D018682:GABA Agents; D011963:Receptors, GABA-A; D003687:Dehydroepiandrosterone; D005680:gamma-Aminobutyric Acid; D011280:Pregnanolone; C036150:beta-carboline-3-carboxylic acid methyl ester